Bicara Therapeutics

Bicara Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. With a team of 24 employees, the company focuses on developing innovative therapeutics in the field of oncology. Bicara Therapeutics specializes in designing and developing biologics that combine targeted therapy with tumor modulators. Their dual-action biologics are engineered to deliver immunomodulatory payloads directly to the tumor microenvironment, aiming to enhance immune cell activity and potentially achieve long-lasting treatment effects. Bicara Therapeutics distinguishes itself through its unique approach of combining precision targeting with tumor modulation. This strategy aims to deliver a more potent and targeted therapeutic response, potentially leading to improved clinical outcomes for patients. For more information about Bicara Therapeutics and its groundbreaking research, visit their website at bicara.com.